OpportunityTitle: Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR [R41]
Description: Purpose. The goal of this Funding Opportunity Announcement (FOA) issued by the National Institute on Drug Abuse (NIDA) is to facilitate the development of new, more effective treatments for tobacco dependence. Mechanism of Support. This FOA will utilize the STTR (R41) grant mechanisms for Phase I applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of 4-7 projects awarded as a result of this announcement is $1,500,000 for fiscal year 2011. Future year amounts will depend on annual appropriations. Budget and Project Period. For these Phase I projects, budgets up to $300,000 total costs for a time period of up to one year may be requested.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;